[CHM] YoY Quarter Result on 30-Jun-2024 [#Q4]

Stock
[CHM] Chimeric Therapeutics Limited
Announcement Date
28-Jun-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q4]
Profit Trend
QoQ- -100.00%
YoY- -5.68%
Quarter Report
CHM's Result
CHM's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
Revenue -1,756 706 1,309 0 -
PBT -12,809 -15,592 -6,046 -11,511 3.62%
Tax 2,165 -1,423 164 5,682 -27.48%
NP -14,974 -14,169 -6,209 -11,511 9.15%
Tax Rate - - - - -
Total Cost 13,217 14,875 7,518 11,511 4.71%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
NP Margin 852.53 -2,007.51 -474.53 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
EPS -0.02 -0.03 -0.02 -0.03 -12.63%
EPS Diluted -0.02 -0.03 -0.02 -0.03 -12.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.